(NOC) Northrop Grumman - Overview
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NYSE (USA) | Market Cap: 78.427m USD | Total Return: 18.7% in 12m
Avg Turnover: 396M
EPS Trend: 64.6%
Qual. Beats: 0
Rev. Trend: 89.4%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Northrop Grumman Corporation is a global aerospace and defense technology firm organized into four primary segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The company specializes in high-altitude autonomous aircraft, strategic long-range strike capabilities, and advanced missile defense solutions. Its portfolio also includes electronic warfare systems, satellite technology, and hypersonic propulsion systems for international and domestic military applications.
The aerospace and defense sector operates primarily through long-term government contracts, often utilizing a cost-plus or fixed-price billing model. As a prime contractor for the U.S. Department of Defense, Northrop Grumman benefits from high barriers to entry due to the intense capital requirements and specialized technical expertise needed to develop next-generation stealth and space technology.
Investors can further evaluate the companys financial health by reviewing the detailed performance metrics available on ValueRay.
- B-21 Raider production ramp-up drives long-term aeronautics revenue growth
- Sentinel ICBM program development costs impact defense segment margins
- Space Systems growth accelerates through increased military satellite demand
- Elevated Pentagon defense spending levels sustain multi-year contract backlog
- Higher interest rates increase debt service costs for capital-intensive projects
| Net Income: 4.58b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.94 > 1.0 |
| NWC/Revenue: 4.60% < 20% (prev -2.16%; Δ 6.76% < -1%) |
| CFO/TA 0.09 > 3% & CFO 4.67b > Net Income 4.58b |
| Net Debt (16.9b) to EBITDA (7.50b): 2.25 < 3 |
| Current Ratio: 1.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.5m) vs 12m ago -1.66% < -2% |
| Gross Margin: 20.52% > 18% (prev 0.19%; Δ 2.03k% > 0.5%) |
| Asset Turnover: 86.05% > 50% (prev 83.29%; Δ 2.76% > 0%) |
| Interest Coverage Ratio: 8.92 > 6 (EBITDA TTM 7.50b / Interest Expense TTM 671.0m) |
| A: 0.04 (Total Current Assets 14.8b - Total Current Liabilities 12.8b) / Total Assets 50.0b |
| B: 0.34 (Retained Earnings 17.1b / Total Assets 50.0b) |
| C: 0.12 (EBIT TTM 5.99b / Avg Total Assets 49.2b) |
| D: 0.52 (Book Value of Equity 17.1b / Total Liabilities 32.9b) |
| Altman-Z'' = 2.73 = A |
| DSRI: 1.03 (Receivables 9.36b/8.66b, Revenue 42.4b/40.4b) |
| GMI: 0.94 (GM 20.52% / 19.34%) |
| AQI: 0.97 (AQ_t 0.46 / AQ_t-1 0.47) |
| SGI: 1.05 (Revenue 42.4b / 40.4b) |
| TATA: -0.00 (NI 4.58b - CFO 4.67b) / TA 50.0b) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of May 26, 2026, the stock is trading at USD 555.58 with a total of 651,835 shares traded.
Over the past week, the price has changed by +2.75%,
over one month by -3.42%,
over three months by -21.04% and
over the past year by +18.73%.
Northrop Grumman has received a consensus analysts rating of 3.96. Therefore, it is recommended to buy NOC.
- StrongBuy: 10
- Buy: 4
- Hold: 11
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 701.6 | 26.3% |
P/E Trailing = 17.4516
P/E Forward = 19.8807
P/S = 1.8511
P/B = 4.6169
P/EG = 4.1439
Revenue TTM = 42.4b USD
EBIT TTM = 5.99b USD
EBITDA TTM = 7.50b USD
Long Term Debt = 14.4b USD (from longTermDebt, last quarter)
Short Term Debt = 758.0m USD (from shortTermDebt, last quarter)
Debt = 19.0b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.91b
Net Debt = 16.9b USD (calculated: Debt 19.0b - CCE 2.09b)
Enterprise Value = 95.3b USD (78.4b + Debt 19.0b - CCE 2.09b)
Interest Coverage Ratio = 8.92 (Ebit TTM 5.99b / Interest Expense TTM 671.0m)
EV/FCF = 28.84x (Enterprise Value 95.3b / FCF TTM 3.31b)
FCF Yield = 3.47% (FCF TTM 3.31b / Enterprise Value 95.3b)
FCF Margin = 7.80% (FCF TTM 3.31b / Revenue TTM 42.4b)
Net Margin = 10.80% (Net Income TTM 4.58b / Revenue TTM 42.4b)
Gross Margin = 20.52% ((Revenue TTM 42.4b - Cost of Revenue TTM 33.7b) / Revenue TTM)
Gross Margin QoQ = 19.84% (prev 19.60%)
Tobins Q-Ratio = 1.91 (Enterprise Value 95.3b / Total Assets 50.0b)
Interest Expense / Debt = 3.54% (Interest Expense 671.0m / Debt 19.0b)
Taxrate = 15.05% (155.0m / 1.03b)
NOPAT = 5.09b (EBIT 5.99b * (1 - 15.05%))
Current Ratio = 1.15 (Total Current Assets 14.8b / Total Current Liabilities 12.8b)
Debt / Equity = 1.11 (Debt 19.0b / totalStockholderEquity, last quarter 17.1b)
Debt / EBITDA = 2.25 (Net Debt 16.9b / EBITDA 7.50b)
Debt / FCF = 5.11 (Net Debt 16.9b / FCF TTM 3.31b)
Total Stockholder Equity = 16.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.29% (Net Income 4.58b / Total Assets 50.0b)
RoE = 28.05% (Net Income TTM 4.58b / Total Stockholder Equity 16.3b)
RoCE = 19.49% (EBIT 5.99b / Capital Employed (Equity 16.3b + L.T.Debt 14.4b))
RoIC = 13.41% (NOPAT 5.09b / Invested Capital 37.9b)
WACC = 4.84% (E(78.4b)/V(97.4b) * Re(5.29%) + D(19.0b)/V(97.4b) * Rd(3.54%) * (1-Tc(0.15)))
Discount Rate = 5.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -2.57%
[DCF] Terminal Value 77.97% ; FCFF base≈2.69b ; Y1≈3.09b ; Y5≈4.54b
[DCF] Fair Price = 362.5 (EV 68.4b - Net Debt 16.9b = Equity 51.5b / Shares 142.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 64.55 | EPS CAGR: 4.65% | SUE: 0.06 | # QB: 0
Revenue Correlation: 89.38 | Revenue CAGR: 3.22% | SUE: 0.42 | # QB: 0
EPS current Quarter (2026-06-30): EPS=6.81 | Chg30d=-0.58% | Revisions=-25% | Analysts=18
EPS next Quarter (2026-09-30): EPS=7.01 | Chg30d=-0.27% | Revisions=-38% | Analysts=18
EPS current Year (2026-12-31): EPS=27.95 | Chg30d=+0.02% | Revisions=+11% | GrowthEPS=+6.1% | GrowthRev=+4.8%
EPS next Year (2027-12-31): EPS=30.18 | Chg30d=-0.01% | Revisions=+29% | GrowthEPS=+8.0% | GrowthRev=+6.5%
[Analyst] Revisions Ratio: -38%